CAT and diabetic kidney disease: The results indicated a statistically significant difference in CAT activity between the diabetic nephropathy groups, DMT2N1 (p = 0.000128) and DMT2N2 (p = 0.00013), and diabetic patients without complications, DMT2N0 (Figure 3B).